AbCellera Biologics Inc. (ABCL) Social Stream
AbCellera Biologics Inc (ABCL) Price Targets From Analysts
Use the tables below to see what analysts covering AbCellera Biologics Inc think about its future price and what recommendations they have for investors and traders.
| Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|
| 5 | $55 | $25 | $45.4 | $15.92 | 185.18% |
The Trend in the Analyst Price Target
Over the past 36 weeks, ABCL's average price target has gone down $6.
Over the past 36 weeks, ABCL's average upside potential has been 101.5%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-09-20 | 5 | 55 | 25 | 45.4 | 20.65 | 119.85% |
| 2021-09-19 | 5 | 55 | 25 | 45.4 | 20.36 | 122.99% |
| 2021-09-18 | 5 | 55 | 25 | 45.4 | 20.36 | 122.99% |
| 2021-09-11 | 5 | 55 | 25 | 45.4 | 18.99 | 139.07% |
| 2021-09-04 | 5 | 55 | 25 | 45.4 | 18.74 | 142.26% |
| 2021-08-28 | 5 | 55 | 25 | 45.4 | 17.58 | 158.25% |
| 2021-08-14 | 5 | 55 | 25 | 45.8 | 17.89 | 156.01% |
| 2021-08-07 | 5 | 55 | 25 | 47.2 | 14.97 | 215.3% |
| 2021-08-05 | 5 | 55 | 25 | 47.2 | 15.61 | 202.37% |
| 2021-08-01 | 5 | 55 | 25 | 47.2 | 15.17 | 211.14% |
| 2021-07-24 | 5 | 55 | 25 | 47.2 | 15.79 | 198.92% |
| 2021-07-17 | 5 | 55 | 45 | 51.2 | 16.93 | 202.42% |
| 2021-07-10 | 5 | 55 | 45 | 51.2 | 19.37 | 164.33% |
| 2021-07-03 | 5 | 55 | 45 | 51.2 | 20.48 | 150% |
| 2021-06-26 | 5 | 55 | 45 | 51.2 | 20.74 | 146.87% |
| 2021-06-13 | 5 | 55 | 45 | 51.2 | 25.90 | 97.68% |
| 2021-06-05 | 5 | 55 | 45 | 51.2 | 25.97 | 97.15% |
| 2021-05-22 | 5 | 55 | 45 | 51.2 | 32.03 | 59.85% |
| 2021-05-15 | 5 | 55 | 45 | 51.2 | 31.75 | 61.26% |
| 2021-05-08 | 5 | 55 | 45 | 51.6 | 29.09 | 77.38% |
| 2021-04-25 | 5 | 55 | 45 | 52.2 | 29.33 | 77.97% |
| 2021-04-17 | 5 | 55 | 45 | 52.2 | 29.82 | 75.05% |
| 2021-04-10 | 5 | 55 | 45 | 52.4 | 28.35 | 84.83% |
| 2021-04-03 | 5 | 55 | 45 | 52.4 | 30.71 | 70.63% |
| 2021-03-20 | 5 | 61 | 52 | 55.8 | 31.20 | 78.85% |
| 2021-03-13 | 5 | 61 | 52 | 55.8 | 36.54 | 52.71% |
| 2021-03-06 | 5 | 61 | 52 | 55.8 | 28.61 | 95.04% |
| 2021-02-27 | 5 | 61 | 52 | 55.8 | 37.71 | 47.97% |
| 2021-02-20 | 5 | 61 | 52 | 55.8 | 44.07 | 26.62% |
| 2021-02-13 | 5 | 61 | 52 | 55.8 | 42.97 | 29.86% |
| 2021-02-06 | 5 | 61 | 45 | 54.4 | 46.55 | 16.86% |
| 2021-01-30 | 5 | 61 | 45 | 54.4 | 52.83 | 2.97% |
| 2021-01-23 | 5 | 59 | 45 | 51.4 | 50.50 | 1.78% |
| 2021-01-16 | 5 | 59 | 45 | 51.4 | 44.41 | 15.74% |
| 2021-01-09 | 5 | 59 | 45 | 51.4 | 39.72 | 29.41% |
ABCL Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.3 | 2 | 3 | 0 | 0 | 0 | 5 |
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- The upside potential (average analyst target price relative to current price) of ABCL is greater than 88.36% of all US stocks.
- The variance in analysts' estimates of ABCL is less than 14.31% of all US stocks.
- The number of analysts covering the stock of ABCL is higher than 6.61% of stocks in the large market cap category.
- AbCellera Biologics Inc's average analyst price target is greater than 75.18% of Pharmaceutical Products stocks.
In the Pharmaceutical Products industry, ITOS, SBTX and VERU are the three stocks most similar to AbCellera Biologics Inc regarding the price target and analyst recommendation information presented here.
Is ABCL a Buy, Hold or Sell? See the POWR Ratings now!